|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Electronic Letters to:
|
|
Electronic letters published:
|
|
|||
|
Mohamad Abdelsalam, physician ICU
Send letter to journal:
mohamadabdelsalam{at}hotmail.com Mohamad Abdelsalam
|
It is proposed that montelukast unmasks CSS by allowing tapering high doses of inhaled and/or systemic steriods.However,in case 2,the patient continued to deteriorate despite starting montelukast therapy and 3 courses of systemic steriods were given in addition to high-dose inhaled fluticasone allready being given.In otherwards, dose of steriods was increasing Not tapering but the patient developed CSS a few months after montelukast was introduced (despite high-dose inhaled and systemic steriods. | |||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |